Live Breaking News & Updates on Program Registries

Stay updated with breaking news from Program registries. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Castle Biosciences Reports First Quarter 2024 Results

Q1 2024 revenue increased 74% over Q1 2023 to $73 million

Q1 2024 total test reports increased 40% over Q1 2023

Raising full-year 2024 revenue guidance to $255-265 million from $235-240. ....

United States , Castle Biosciences , Derek Maetzold , Program Registries , Mental Health , See The Company , Securities Exchange , Castle Biosciences Inc , National Cancer Institute Surveillance , National Comprehensive Cancer Network , American Joint Committee On Cancer Staging Manual , Medicare Contractors , Decisiondx Melanoma Class , Quarter Ended March , Path Melanoma , Adjusted Gross Margin , Cash Equivalents , Marketable Investment , Recent Accomplishments , American Joint Committee , Cancer Staging Manual , National Cancer Institute , End Results , Investor Relations , Adjusted Revenues , Gross Margin ,

Castle Biosciences Reports First Quarter 2024 Results

Castle Biosciences Reports First Quarter 2024 Results
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United States , Castle Biosciences , Program Registries , National Cancer Institute Surveillance , See The Company , Castle Biosciences Inc , Securities Exchange , National Comprehensive Cancer Network , American Joint Committee On Cancer Staging Manual , Mental Health , Medicare Contractors , Decisiondx Melanoma Class , Quarter Ended March , Path Melanoma , Cypher Barrett , Adjusted Gross Margin , Cash Equivalents , Marketable Investment , Recent Accomplishments , American Joint Committee , Cancer Staging Manual , National Cancer Institute , Investor Relations , Adjusted Revenues , Gross Margin , Adjusted Gross ,

Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results

Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Camilla Zuckero , Castle Biosciences , Kristen Oelschlager , Derek Maetzold , Program Registries , Mental Health , Healthcare Technology Report Top , Castle Biosciences Inc , See The Company , Securities Exchange , National Cancer Institute Surveillance , American Joint Committee On Cancer , National Comprehensive Cancer Network , Months Ended , Cypher Barrett , Cash Equivalents , Marketable Investment , Quarter Ended , Path Melanoma , Recent Accomplishments , Advanced Practitioner , American Joint Committee , National Cancer Institute , End Results , Aesthetic Dermatology ,

Castle Bio Q2 Revenues Beat Expectations With 44 Percent Rise

Despite recent reimbursement struggles, the company said it was raising its full year guidance above its previously estimated $170 million to $180 million. ....

United States , Castle Biosciences , Derek Maetzold , Tissuecypher Barrett , Castle Decisiondx , Centers For Medicare , Program Registries , National Cancer Institute , Medicaid Service Moldx , Mypath Melanoma ,

Study Data from Castle Biosciences' Collaboration with the National Cancer Institute's SEER Program Registries Published in JCO Precision Oncology

Data shows testing with DecisionDx®-Melanoma provided significant prognostic information regarding survival outcomes ....

United States , Matthew Goldberg , Derek Maetzold , Castle Biosciences , Castle Biosciences Inc , Program Registries , American Joint Committee On Cancer Eighth Edition , Securities Exchange , American Joint Committee , Cancer Eighth Edition , Decisiondx Melanoma , Mypath Melanoma , Securities Act , Securities Exchange Act , Quarterly Report , Gene Expression Profile Testing , Cutaneous Melanoma , Survival Outcomes , Population Based Analysis ,